STORM believes in partnering as a strategic choice to innovate, create value and accelerate its pipeline. STORM has a close and interactive relationship with its scientific founders but will also seek and partner with the best scientists worldwide to underpin its drug discovery. The highest quality CRO partners are selected to aid our drug discovery in a mixed model of in house and outsourced activities. Furthermore, STORM recognises the value that larger pharmaceutical and biotechnology companies can bring in terms of expertise and resources and actively seeks partners for the growing number of discovery opportunities it has created from its discovery platform.

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2023 Dates To be Confirmed